Skip to content

Author

Dipen Purohit

We have 4 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Translational Horizons in Targeted Oncology: Mechanistic Insights, Therapeutic Innovations, and Clinical Impact.

The identification of new molecular targets and the growth of personalized therapies for cancer depend on current studies, and it is believed that new advances in molecular science will contribute to the development of innovative and successful methods for therapy, and eventually decrease the prevalence of malignancies...

Hardha Balachandran, Gowramma Byran, S. Murugesan et al. · 0 citations
Sep 2026

Rational Design and In Silico Evaluation of a Dual-Action Antimicrobial Peptide Targeting Efflux Pump and Membrane Integrity in Pseudomonas aeruginosa.

2ANN is identified as a promising AMP candidate for further investigation against MDR P. aeruginosa, as the findings are based exclusively on computational prediction and simulation, experimental validation is required to confirm its biological activity and mechanism of action.

D. G. T. Parambi, P. Prabitha, T. Alsahli et al. · 0 citations
Sep 2026

Computational Identification of Shikimic Acid Derivatives as Potential SARS-CoV-2 Inhibitors: An In Silico Approach.

The docking, ADMET, and MD simulation studies indicate that the designed shikimic acid derivatives have good binding affinity and drug-like properties, and are stable in the active site of the SARS-CoV-2 main protease.

Hardha Balachandran, Kaviarasan Lakshmanan, Dipen Purohit et al. · 0 citations
Review Aug 2026

Multi-target Drug Discovery for Cancer Therapy: A Contemporary Review.

MKIs and bispecific antibodies represent transformative modalities in modern oncology, supported by robust clinical evidence and extensive patent activity.

Thirumalaikumaran Rathinam, S. Reddy, Yella Sirisha et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.